|
Jun 26
|
Quince Therapeutics doses first subject in Ataxia-Telangiectasia trial
|
|
Jun 25
|
Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia
|
|
May 13
|
Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
|
|
May 6
|
Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
|
|
Apr 1
|
Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
|
|
Mar 8
|
The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech
|
|
Dec 4
|
10 Best Debt Free Penny Stocks To Buy Now
|
|
Aug 10
|
Quince Therapeutics to Present at Sidoti Virtual Investor Conference on August 17, 2023
|